Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.4K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.4K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

5.2K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.2K
Stem Cell Culture01:17

Stem Cell Culture

5.8K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Threshold Effect of Cumulative Postnatal Corticosteroid Dose on Long-Term Outcomes in Extremely Preterm Infants.

Journal of clinical medicine·2026
Same author

Preliminary Report of a Nationwide Prospective Cohort of Congenital Diaphragmatic Hernia in Korea.

Journal of Korean medical science·2026
Same author

Two-Year Outcomes of a Randomized Controlled Trial of Nonintervention Versus Oral Ibuprofen for Patent Ductus Arteriosus in Premature Infants.

Journal of Korean medical science·2026
Same author

Advances in the Use of Cell-Based Therapies for Prevention of Bronchopulmonary Dysplasia.

Clinics in perinatology·2026
Same author

Five-year follow-up outcomes after phase 1 trial of mesenchymal stromal cells for periventricular hemorrhagic infarction in preterm infants.

Stem cells translational medicine·2026
Same author

Neonatal urinary phthalate metabolite concentrations are associated with the development of atopic dermatitis.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026

Related Experiment Video

Updated: Nov 20, 2025

Neonatal Cardiac Scaffolds: Novel Matrices for Regenerative Studies
08:16

Neonatal Cardiac Scaffolds: Novel Matrices for Regenerative Studies

Published on: November 5, 2016

8.0K

Mesenchymal stem cell therapy for intractable neonatal disorders.

So Yoon Ahn1, Won Soon Park2, Se In Sung3

  • 1Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea; Stem Cell and Regenerative Medicine Institute, Samsung Medical Center, Seoul, South Korea.

Pediatrics and Neonatology
|January 24, 2021
PubMed
Summary

Mesenchymal stem cell (MSC) therapy shows promise for treating serious newborn conditions like BPD, IVH, and HIE. MSCs promote tissue repair through anti-inflammatory and regenerative effects, offering new therapeutic avenues.

Keywords:
clinical trialinfant, newbornstem cell transplantationstem cells

More Related Videos

Intratracheal Instillation of Stem Cells in Term Neonatal Rats
04:27

Intratracheal Instillation of Stem Cells in Term Neonatal Rats

Published on: May 4, 2020

5.9K
Evaluation of Stem Cell Therapies in a Bilateral Patellar Tendon Injury Model in Rats
09:31

Evaluation of Stem Cell Therapies in a Bilateral Patellar Tendon Injury Model in Rats

Published on: March 30, 2018

11.5K

Related Experiment Videos

Last Updated: Nov 20, 2025

Neonatal Cardiac Scaffolds: Novel Matrices for Regenerative Studies
08:16

Neonatal Cardiac Scaffolds: Novel Matrices for Regenerative Studies

Published on: November 5, 2016

8.0K
Intratracheal Instillation of Stem Cells in Term Neonatal Rats
04:27

Intratracheal Instillation of Stem Cells in Term Neonatal Rats

Published on: May 4, 2020

5.9K
Evaluation of Stem Cell Therapies in a Bilateral Patellar Tendon Injury Model in Rats
09:31

Evaluation of Stem Cell Therapies in a Bilateral Patellar Tendon Injury Model in Rats

Published on: March 30, 2018

11.5K

Area of Science:

  • Neonatal Medicine
  • Regenerative Medicine
  • Stem Cell Biology

Background:

  • Neonatal disorders such as bronchopulmonary dysplasia (BPD), intraventricular hemorrhage (IVH), and hypoxic-ischemic encephalopathy (HIE) present significant therapeutic challenges.
  • Mesenchymal stem cells (MSCs) are being investigated for their potential to treat these complex neonatal conditions.

Purpose of the Study:

  • To review recent advancements in using MSCs for the prevention and treatment of neonatal BPD, IVH, and HIE.
  • To highlight preclinical and clinical data supporting MSC-based therapies for these disorders.

Main Methods:

  • Review of current scientific literature on mesenchymal stem cell transplantation in neonates.
  • Analysis of preclinical studies and clinical trial data concerning MSCs for BPD, IVH, and HIE.

Main Results:

  • MSCs exert therapeutic effects through paracrine signaling, releasing factors with anti-inflammatory, anti-oxidative, anti-apoptotic, and anti-fibrotic properties.
  • These paracrine actions facilitate the regeneration of damaged cells and tissues in affected neonatal organs.

Conclusions:

  • MSC transplantation represents a promising therapeutic strategy for intractable neonatal disorders.
  • Further research and clinical application of MSCs could significantly improve outcomes for newborns with BPD, IVH, and HIE.